Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval for Bylvay ® (odevixibat) for the treatment of pruritus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback